RCM Leaders Focus on Denial and Error Reduction
Revenue cycle management continues to be a critical area of focus for healthcare finance leaders. Promantra released its "2026 RCM Playbook" for CFOs, concentrating on cutting denials and improving cash flow. The release coincides with ongoing industry dialogue about persistent revenue leaks from claim errors and patient-pay issues, prompting calls for organizations to tighten their billing processes.
- Payer behavior has surpassed internal staffing as the primary risk to revenue growth, with 62% of RCM leaders citing denials and underpayments as their top obstacle for 2026. - The cost to rework a single denied claim can range from $25 to $181, contributing to an estimated $25.7 billion spent annually by providers on claim adjudication. - Missing or incorrect prior authorizations remain a leading cause of denials; a new CMS rule taking effect in 2026 mandates that payers must respond to urgent electronic prior authorization requests within 72 hours and standard requests within 7 days. - To combat high denial rates, over 92% of RCM leaders plan to expand AI initiatives in 2026, with some organizations reporting 13-37% fewer denials after implementing AI-driven workflows. - Common administrative errors that trigger denials include incorrect patient demographic or insurance information, procedure codes that do not match the prior authorization, and a lack of documentation to support medical necessity. - A recent survey found RCM teams spend between 51 and 75 hours each week managing work related to denials, with 47% of organizations losing 3-4% of net patient revenue due to denied claims and underpayments. - Rising patient financial responsibility is a growing factor, as out-of-pocket expenditures are projected to increase by 3.7% in 2026, while provider collection rates from commercially insured patients have already fallen to 34.4%. - Payers are increasingly using AI and Natural Language Processing (NLP) to "read" clinical notes at scale, triggering automated audits and denials for claims with generic or unspecified ("NOS") codes.
